Jump to content

Western blot

From Wikipedia, the free encyclopedia
(Redirected from Western-Blot)
Western blot workflow

The western blot (sometimes called the protein immunoblot), or western blotting, is a widely used analytical technique in molecular biology and immunogenetics to detect specific proteins in a sample of tissue homogenate or extract.[1] Besides detecting the proteins, this technique is also utilized to visualize, distinguish, and quantify the different proteins in a complicated protein combination.[2]

Western blot technique uses three elements to achieve its task of separating a specific protein from a complex: separation by size, transfer of protein to a solid support, and marking target protein using a primary and secondary antibody to visualize.[1] A synthetic or animal-derived antibody (known as the primary antibody) is created that recognizes and binds to a specific target protein. The electrophoresis membrane is washed in a solution containing the primary antibody, before excess antibody is washed off.[3] A secondary antibody is added which recognizes and binds to the primary antibody. The secondary antibody is visualized through various methods such as staining, immunofluorescence, and radioactivity, allowing indirect detection of the specific target protein.[3]

Other related techniques include dot blot analysis, quantitative dot blot, immunohistochemistry and immunocytochemistry, where antibodies are used to detect proteins in tissues and cells by immunostaining, and enzyme-linked immunosorbent assay (ELISA).

The name western blot is a play on the Southern blot, a technique for DNA detection named after its inventor, English biologist Edwin Southern. Similarly, detection of RNA is termed as northern blot.[4] The term "western blot" was given by W. Neal Burnette in 1981,[5] although the method itself was independently invented in 1979 by Jaime Renart, Jakob Reiser, and George Stark at Stanford University,[6] and by Harry Towbin, Theophil Staehelin, and Julian Gordon at the Friedrich Miescher Institute in Basel, Switzerland.[7] The Towbin group also used secondary antibodies for detection, thus resembling the actual method that is almost universally used today. Between 1979 and 2019 "it has been mentioned in the titles, abstracts, and keywords of more than 400,000 PubMed-listed publications" and may still be the most used protein-analytical technique.[8]

Applications

[edit]
Western blot HIV test where first two strips are negative and positive controls followed by actual tests

The western blot is extensively used in biochemistry for the qualitative detection of single proteins and protein-modifications (such as post-translational modifications). At least 8–9% of all protein-related publications are estimated to apply western blots.[8] It is used as a general method to identify the presence of a specific single protein within a complex mixture of proteins. A semi-quantitative estimation of a protein can be derived from the size and colour intensity of a protein band on the blot membrane. In addition, applying a dilution series of a purified protein of known concentrations can be used to allow a more precise estimate of protein concentration. The western blot is routinely used for verification of protein production after cloning. It is also used in medical diagnostics, e.g., in the HIV test or BSE-Test.[9]

The confirmatory HIV test employs a western blot to detect anti-HIV antibody in a human serum sample. Proteins from known HIV-infected cells are separated and blotted on a membrane as above. Then, the serum to be tested is applied in the primary antibody incubation step; free antibody is washed away, and a secondary anti-human antibody linked to an enzyme signal is added. The stained bands then indicate the proteins to which the patient's serum contains antibody.[10] A western blot is also used as the definitive test for variant Creutzfeldt–Jakob disease, a type of prion disease linked to the consumption of contaminated beef from cattle with bovine spongiform encephalopathy (BSE, commonly referred to as 'mad cow disease').[11] Another application is in the diagnosis of tularemia. An evaluation of the western blot's ability to detect antibodies against F. tularensis revealed that its sensitivity is almost 100% and the specificity is 99.6%.[12] Some forms of Lyme disease testing employ western blotting.[13] A western blot can also be used as a confirmatory test for Hepatitis B infection and HSV-2 (Herpes Type 2) infection.[14][15] In veterinary medicine, a western blot is sometimes used to confirm FIV+ status in cats.[16]

Further applications of the western blot technique include its use by the World Anti-Doping Agency (WADA). Blood doping is the misuse of certain techniques and/or substances to increase one's red blood cell mass, which allows the body to transport more oxygen to muscles and therefore increase stamina and performance. There are three widely known substances or methods used for blood doping, namely, erythropoietin (EPO), synthetic oxygen carriers and blood transfusions. Each is prohibited under WADA's List of Prohibited Substances and Methods. The western blot technique was used during the 2014 FIFA World Cup in the anti-doping campaign for that event.[17] In total, over 1000 samples were collected and analysed by Reichel, et al.[18] in the WADA accredited Laboratory of Lausanne, Switzerland. Recent research utilizing the western blot technique showed an improved detection of EPO in blood and urine based on novel Velum SAR precast horizontal gels optimized for routine analysis.[19] With the adoption of the horizontal SAR-PAGE in combination with the precast film-supported Velum SAR gels the discriminatory capacity of micro-dose application of rEPO was significantly enhanced.

In addition to the application of western blot in scientific research, it is also utilized in clinical research areas. Since it can be applied to the direct protein identification process, western blot is regarded as a powerful diagnostic tool that is frequently used in the clinic setting. WB and protein detection techniques can be used to find disease biomarkers like specific proteins or antibodies. It is thought to be a viable method for identifying particular proteins during the diagnosis of diseases like cancer, autoimmune disease, and prion disorders. The detection of several biomarkers used in the diagnosis of neurological and oncological illnesses by Western blotting is a common procedure.[2][20][21] For instance, it is widely believed that the advent of multidrug resistance (MDR) has made effective cancer therapy extremely challenging. Therefore, early, accurate, and sensitive MDR mechanism discovery is essential, as is the search for more effective chemotherapeutic approaches for application in clinical settings. The expression of MDR1/P-glycoprotein in the P388/ADR, P388 and HCT-15 cell lines is examined using the WB technique. WB has also identified MRP1 levels.[2][22][23]

On the other hand, as western blot has the potential to distinguish different protein isoforms, it may be used to diagnose prion and protein isoform-related diseases, such as cancer. For instance, the western blotting analysis of the isoform pattern of 14-3-3 proteins in cerebral fluid can identify Creutzfeldt-Jakob disease.[2][24] Also, Farmers lung disease is a pulmonary condition brought on by breathing antigenic particles, and studies have indicated that western blot may be a useful option for identifying immunoreactive proteins related to farmers lung disease.[2] Besides, western blot is also used to identify proteins in synovial fluid and serum, enabling the diagnosis of osteoarthritis and rheumatoid arthritis clinical symptoms.[2][25] western blot is used to assess the levels of FSTL1 protein expression in individuals with knee osteoarthritis, which serves as a potential biomarker of articular damage.[2][26] Additionally, it is used to identify proteins in synovial fluid and serum, enabling the diagnosis of osteoarthritis and rheumatoid arthritis clinical symptoms. It is used to assess the levels of FSTL1 protein expression in individuals with knee osteoarthritis, which serves as a potential biomarker of articular damage.[2][27][28]

Identification of protein localization across cells

[edit]

For medication development, the identification of therapeutic targets, and biological research, it is essential to comprehend where proteins are located within a cell.[2][29] The subcellular locations of proteins inside the cell and their functions are closely related. The relationship between protein function and localization suggests that when proteins move, their functions may change or acquire new characteristics. A protein's subcellular placement can be determined using a variety of methods. Numerous efficient and reliable computational tools and strategies have been created and used to identify protein subcellular localization.[30] With the aid of subcellular fractionation methods, WB continues to be an important fundamental method for the investigation and comprehension of protein localization.[2]

Epitope mapping

[edit]

Due to their various epitopes, antibodies have gained interest in both basic and clinical research. The foundation of antibody characterization and validation is epitope mapping. The procedure of identifying an antibody's binding sites (epitopes) on the target protein is referred to as "epitope mapping." Finding the binding epitope of an antibody is essential for the discovery and creation of novel vaccines, diagnostics, and therapeutics.[2] As a result, various methods for mapping antibody epitopes have been created. At this point, western blotting's specificity is the main feature that sets it apart from other epitope mapping techniques. There are several application of western blot for epitope mapping on human skin samples, hemorrhagic disease virus.[2][31][32]

Procedure

[edit]
From gel to publication

The western blot method is composed of gel electrophoresis to separate native proteins by 3-D structure or denatured proteins by the length of the polypeptide, followed by an electrophoretic transfer onto a membrane (mostly PVDF or nitrocellulose) and an immunostaining procedure to visualize a certain protein on the blot membrane.

Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) is generally used for the denaturing electrophoretic separation of proteins. Sodium dodecyl sulfate (SDS) is generally used as a buffer (as well as in the gel) in order to give all proteins present a uniform negative charge, since proteins can be positively, negatively, or neutrally charged. Prior to electrophoresis, protein samples are often boiled to denature the proteins present. This ensures that proteins are separated based on size and prevents proteases (enzymes that break down proteins) from degrading samples. Following electrophoretic separation, the proteins are transferred to a membrane (typically nitrocellulose or PVDF). The membrane is often then stained with Ponceau S in order to visualize the proteins on the blot and ensure a proper transfer occurred. Next the proteins are blocked with milk (or other blocking agents) to prevent non-specific antibody binding, and then stained with antibodies specific to the target protein.[7][6] Lastly, the membrane will be stained with a secondary antibody that recognizes the first antibody staining, which can then be used for detection by a variety of methods. The gel electrophoresis step is included in western blot analysis to resolve the issue of the cross-reactivity of antibodies.

Sample Preparation

[edit]

As a significant step in conducting a western blot, sample preparation has to be done effectively since the interpretation of this assay is influenced by the protein preparation, which is composed of protein extraction and purification processes.[33][3] To achieve efficient protein extraction, a proper homogenization method needs to be chosen due to the fact that it is responsible for bursting the cell membrane and releasing the intracellular components.[3][34] Besides that, the ideal lysis buffer is needed to acquire substantial amounts of target protein content because the buffer is leading the process of protein solubilization and preventing protein degradation. After completing the sample preparation, the protein content is ready to be separated by the utilization of gel electrophoresis.[3]

Gel electrophoresis

[edit]
Main article: Gel electrophoresis
SDS-PAGE electrophoresis

The proteins of the sample are separated using gel electrophoresis. Separation of proteins may be by isoelectric point (pI), molecular weight, electric charge, or a combination of these factors. The nature of the separation depends on the treatment of the sample and the nature of the gel.

By far the most common type of gel electrophoresis employs polyacrylamide gels and buffers loaded with sodium dodecyl sulfate (SDS). SDS-PAGE (SDS-polyacrylamide gel electrophoresis) maintains polypeptides in a denatured state once they have been treated with strong reducing agents to remove secondary and tertiary structure (e.g. disulfide bonds [S-S] to sulfhydryl groups [SH and SH]) and thus allows separation of proteins by their molecular mass. Sampled proteins become covered in the negatively charged SDS, effectively becoming anionic, and migrate towards the positively charged (higher voltage) anode (usually having a red wire) through the acrylamide mesh of the gel. Smaller proteins migrate faster through this mesh, and the proteins are thus separated according to size (usually measured in kilodaltons, kDa). The concentration of acrylamide determines the resolution of the gel – the greater the acrylamide concentration, the better the resolution of lower molecular weight proteins. The lower the acrylamide concentration, the better the resolution of higher molecular weight proteins. Proteins travel only in one dimension along the gel for most blots.

Samples are loaded into wells in the gel. One lane is usually reserved for a marker or ladder, which is a commercially available mixture of proteins of known molecular weights, typically stained so as to form visible, coloured bands. When voltage is applied along the gel, proteins migrate through it at different speeds dependent on their size. These different rates of advancement (different electrophoretic mobilities) separate into bands within each lane. Protein bands can then be compared to the ladder bands, allowing estimation of the protein's molecular weight.

It is also possible to use a two-dimensional gel which spreads the proteins from a single sample out in two dimensions. Proteins are separated according to isoelectric point (pH at which they have a neutral net charge) in the first dimension, and according to their molecular weight in the second dimension.

Transfer

[edit]
Western blot transfer

To make the proteins accessible to antibody detection, they are moved from within the gel onto a membrane, a solid support, which is an essential part of the process. There are two types of membrane: nitrocellulose (NC) or polyvinylidene difluoride (PVDF). NC membrane has high affinity for protein and its retention abilities. However, NC is brittle, and does not allow the blot to be used for re-probing, whereas PVDF membrane allows the blot to be re-probed.[1] The most commonly used method for transferring the proteins is called electroblotting. Electroblotting uses an electric current to pull the negatively charged proteins from the gel towards the positively charged anode, and into the PVDF or NC membrane. The proteins move from within the gel onto the membrane while maintaining the organization they had within the gel. An older method of transfer involves placing a membrane on top of the gel, and a stack of filter papers on top of that. The entire stack is placed in a buffer solution which moves up the paper by capillary action, bringing the proteins with it. In practice this method is not commonly used due to the lengthy procedure time.

As a result of either transfer process, the proteins are exposed on a thin membrane layer for detection. Both varieties of membrane are chosen for their non-specific protein binding properties (i.e. binds all proteins equally well). Protein binding is based upon hydrophobic interactions, as well as charged interactions between the membrane and protein. Nitrocellulose membranes are cheaper than PVDF, but are far more fragile and cannot withstand repeated probings.

Total protein staining

[edit]
Western blot binding

Total protein staining allows the total protein that has been successfully transferred to the membrane to be visualised, allowing the user to check the uniformity of protein transfer and to perform subsequent normalization of the target protein with the actual protein amount per lane. Normalization with the so-called "loading control" was based on immunostaining of housekeeping proteins in the classical procedure, but is heading toward total protein staining recently, due to multiple benefits.[35] At least seven different approaches for total protein staining have been described for western blot normalization: Ponceau S, stain-free techniques, Sypro Ruby, Epicocconone, Coomassie R-350, Amido Black, and Cy5.[35] In order to avoid noise of signal, total protein staining should be performed before blocking of the membrane. Nevertheless, post-antibody stainings have been described as well.[36]

Blocking

[edit]

Since the membrane has been chosen for its ability to bind protein and as both antibodies and the target are proteins, steps must be taken to prevent the interactions between the membrane and the antibody used for detection of the target protein. Blocking of non-specific binding is achieved by placing the membrane in a dilute solution of protein – typically 3–5% bovine serum albumin (BSA) or non-fat dry milk (both are inexpensive) in tris-buffered saline (TBS) or I-Block, with a minute percentage (0.1%) of detergent such as Tween 20 or Triton X-100. Although non-fat dry milk is preferred due to its availability, an appropriate blocking solution is needed as not all proteins in milk are compatible with all the detection bands.[1] The protein in the dilute solution attaches to the membrane in all places where the target proteins have not attached. Thus, when the antibody is added, it cannot bind to the membrane, and therefore the only available binding site is the specific target protein. This reduces background in the final product of the western blot, leading to clearer results, and eliminates false positives.

Incubation

[edit]
Probing process

During the detection process, the membrane is "probed" for the protein of interest with a modified antibody which is linked to a reporter enzyme; when exposed to an appropriate substrate, this enzyme drives a colorimetric reaction and produces a colour. For a variety of reasons, this traditionally takes place in a two-step process, although there are now one-step detection methods available for certain applications.

Primary antibody

[edit]

The primary antibodies are generated when a host species or immune cell culture is exposed to the protein of interest (or a part thereof). Normally, this is part of the immune response, whereas here they are harvested and used as sensitive and specific detection tools that bind the protein directly.

After blocking, a solution of primary antibody (generally between 0.5 and 5 micrograms/mL) diluted in either PBS or TBST wash buffer is incubated with the membrane under gentle agitation for typically an hour at room temperature, or overnight at 4°C. It can also be incubated at different temperatures, with lesser temperatures being associated with more binding, both specific (to the target protein, the "signal") and non-specific ("noise"). Following incubation, the membrane is washed several times in wash buffer to remove unbound primary antibody, and thereby minimize background.[1] Typically, the wash buffer solution is composed of buffered saline solution with a small percentage of detergent, and sometimes with powdered milk or BSA.

Secondary antibody

[edit]

After rinsing the membrane to remove unbound primary antibody, the membrane is exposed to another antibody known as the secondary antibody. Antibodies come from animal sources (or animal sourced hybridoma cultures). The secondary antibody recognises and binds to the species-specific portion of the primary antibody. Therefore, an anti-mouse secondary antibody will bind to almost any mouse-sourced primary antibody, and can be referred to as an 'anti-species' antibody (e.g. anti-mouse, anti-goat etc.). To allow detection of the target protein, the secondary antibody is commonly linked to biotin or a reporter enzyme such as alkaline phosphatase or horseradish peroxidase. This means that several secondary antibodies will bind to one primary antibody and enhance the signal, allowing the detection of proteins of a much lower concentration than would be visible by SDS-PAGE alone.

Horseradish peroxidase is commonly linked to secondary antibodies to allow the detection of the target protein by chemiluminescence. The chemiluminescent substrate is cleaved by horseradish peroxidase, resulting in the production of luminescence. Therefore, the production of luminescence is proportional to the amount of horseradish peroxidase-conjugated secondary antibody, and therefore, indirectly measures the presence of the target protein. A sensitive sheet of photographic film is placed against the membrane, and exposure to the light from the reaction creates an image of the antibodies bound to the blot. A cheaper but less sensitive approach utilizes a 4-chloronaphthol stain with 1% hydrogen peroxide; the reaction of peroxide radicals with 4-chloronaphthol produces a dark purple stain that can be photographed without using specialized photographic film.

As with the ELISPOT and ELISA procedures, the enzyme can be provided with a substrate molecule that will be converted by the enzyme to a coloured reaction product that will be visible on the membrane (see the figure below with blue bands).

Another method of secondary antibody detection utilizes a near-infrared fluorophore-linked antibody. The light produced from the excitation of a fluorescent dye is static, making fluorescent detection a more precise and accurate measure of the difference in the signal produced by labeled antibodies bound to proteins on a western blot. Proteins can be accurately quantified because the signal generated by the different amounts of proteins on the membranes is measured in a static state, as compared to chemiluminescence, in which light is measured in a dynamic state.[37]

A third alternative is to use a radioactive label rather than an enzyme coupled to the secondary antibody, such as labeling an antibody-binding protein like Staphylococcus Protein A or Streptavidin with a radioactive isotope of iodine. Since other methods are safer, quicker, and cheaper, this method is now rarely used; however, an advantage of this approach is the sensitivity of auto-radiography-based imaging, which enables highly accurate protein quantification when combined with optical software (e.g. Optiquant).

One step

[edit]

Historically, the probing process was performed in two steps because of the relative ease of producing primary and secondary antibodies in separate processes. This gives researchers and corporations huge advantages in terms of flexibility, reduction of cost, and adds an amplification step to the detection process. Given the advent of high-throughput protein analysis and lower limits of detection, however, there has been interest in developing one-step probing systems that would allow the process to occur faster and with fewer consumables. This requires a probe antibody which both recognizes the protein of interest and contains a detectable label, probes which are often available for known protein tags. The primary probe is incubated with the membrane in a manner similar to that for the primary antibody in a two-step process, and then is ready for direct detection after a series of wash steps.

Detection and visualization

[edit]
Western blot chemiluminescent detection

After the unbound probes are washed away, the western blot is ready for detection of the probes that are labeled and bound to the protein of interest. In practical terms, not all westerns reveal protein only at one band in a membrane. Size approximations are taken by comparing the stained bands to that of the marker or ladder loaded during electrophoresis. The process is commonly repeated for a structural protein, such as actin or tubulin, that should not change between samples. The amount of target protein is normalized to the structural protein to control between groups. A superior strategy is the normalization to the total protein visualized with trichloroethanol[38][39] or epicocconone.[40] This practice ensures correction for the amount of total protein on the membrane in case of errors or incomplete transfers. (see western blot normalization)

Colorimetric detection

[edit]

The colorimetric detection method depends on incubation of the western blot with a substrate that reacts with the reporter enzyme (such as peroxidase) that is bound to the secondary antibody. This converts the soluble dye into an insoluble form of a different colour that precipitates next to the enzyme and thereby stains the membrane. Development of the blot is then stopped by washing away the soluble dye. Protein levels are evaluated through densitometry (how intense the stain is) or spectrophotometry.

Chemiluminescent detection

[edit]

Chemiluminescent detection methods depend on incubation of the western blot with a substrate that will luminesce when exposed to the reporter on the secondary antibody. The light is then detected by CCD cameras which capture a digital image of the western blot or photographic film. The use of film for western blot detection is slowly disappearing because of non linearity of the image (non accurate quantification). The image is analysed by densitometry, which evaluates the relative amount of protein staining and quantifies the results in terms of optical density. Newer software allows further data analysis such as molecular weight analysis if appropriate standards are used.

Radioactive detection

[edit]

Radioactive labels do not require enzyme substrates, but rather, allow the placement of medical X-ray film directly against the western blot, which develops as it is exposed to the label and creates dark regions which correspond to the protein bands of interest (see image above). The importance of radioactive detections methods is declining due to its hazardous radiation [citation needed], because it is very expensive, health and safety risks are high, and ECL (enhanced chemiluminescence) provides a useful alternative.

Fluorescent detection

[edit]
Western blot using an anti-lipoic acid primary antibody and an IR-dye labelled secondary antibody in Leishmania major extracts.

The fluorescently labeled probe is excited by light and the emission of the excitation is then detected by a photosensor such as a CCD camera equipped with appropriate emission filters which captures a digital image of the western blot and allows further data analysis such as molecular weight analysis and a quantitative western blot analysis. Fluorescence is considered to be one of the best methods for quantification but is less sensitive than chemiluminescence.[41]

Secondary probing

[edit]

One major difference between nitrocellulose and PVDF membranes relates to the ability of each to support "stripping" antibodies off and reusing the membrane for subsequent antibody probes. While there are well-established protocols available for stripping nitrocellulose membranes, the sturdier PVDF allows for easier stripping, and for more reuse before background noise limits experiments. Another difference is that, unlike nitrocellulose, PVDF must be soaked in 95% ethanol, isopropanol or methanol before use. PVDF membranes also tend to be thicker and more resistant to damage during use.[42]

Minimum requirement specification for Western Blot

[edit]

In order to ensure that the results of Western blots are reproducible, it is important to report the various parameters mentioned above, including specimen preparation, the concentration of protein used for loading, the percentage of gel and running condition, various transfer methods, attempting to block conditions, the concentration of antibodies, and identification and quantitative determination methods. Many of the articles that have been published don't cover all of these variables. Hence, it is crucial to describe different experimental circumstances or parameters in order to increase the repeatability and precision of WB. To increase WB repeatability, a minimum reporting criteria is thus required.[2][43]

2-D gel electrophoresis

[edit]
Main article: Two-dimensional gel electrophoresis

Two-dimensional SDS-PAGE uses the principles and techniques outlined above. 2-D SDS-PAGE, as the name suggests, involves the migration of polypeptides in 2 dimensions. For example, in the first dimension, polypeptides are separated according to isoelectric point, while in the second dimension, polypeptides are separated according to their molecular weight. The isoelectric point of a given protein is determined by the relative number of positively (e.g. lysine, arginine) and negatively (e.g. glutamate, aspartate) charged amino acids, with negatively charged amino acids contributing to a low isoelectric point and positively charged amino acids contributing to a high isoelectric point. Samples could also be separated first under nonreducing conditions using SDS-PAGE, and under reducing conditions in the second dimension, which breaks apart disulfide bonds that hold subunits together. SDS-PAGE might also be coupled with urea-PAGE for a 2-dimensional gel.

In principle, this method allows for the separation of all cellular proteins on a single large gel. A major advantage of this method is that it often distinguishes between different isoforms of a particular protein – e.g. a protein that has been phosphorylated (by addition of a negatively charged group). Proteins that have been separated can be cut out of the gel and then analysed by mass spectrometry, which identifies their molecular weight.

[edit]

Detection problems

[edit]

There may be a weak or absent signal in the band for a number of reasons related to the amount of antibody and antigen used. This problem might be resolved by using the ideal antigen and antibody concentrations and dilutions specified in the supplier's data sheet. Increasing the exposition period in the detection system's software can address weak bands caused by lower sample and antibody concentrations.[2]

Multiple band problems

[edit]

When the protein is broken down by proteases, several bands other than predicted bands of low molecular weight might appear. The development of numerous bands can be prevented by properly preparing protein samples with enough protease inhibitors. Multiple bands might show up in the high molecular weight region because some proteins form dimers, trimers, and multimers; this issue might be solved by heating the sample for longer periods of time. Proteins with post-translational modifications (PTMs) or numerous isoforms cause several bands to appear at various molecular weight areas. PTMs can be removed from a specimen using specific chemicals, which also remove extra bands.[2]

High background

[edit]

Strong antibody concentrations, inadequate blocking, inadequate washing, and excessive exposure time during imaging can result in a high background in the blots. A high background in the blots could be avoided by fixing these issues.[2]

Irregular and uneven bands

[edit]

It has been claimed that a variety of odd and unequal bands, including black dots, white spots or bands, and curving bands, have occurred. The block dots are removed from the blots by effective blocking. White patches develop as a result of bubbles between the membrane and gel. White bands appear in the blots when main and secondary antibodies are present in significant concentrations. Because of the high voltage used during the gel run and the rapid protein migration, smiley bands appear in the blots. The strange bands in the blot are resolved by resolving these problems.[2]

[edit]

During the western blotting, there could be several problems related to the different steps of this procedure. Those problems could originate from a protein analysis step such as the detection of low- or post-translationally modified proteins. Additionally, they can be based on the selection of antibodies since the quality of the antibodies plays a significant role in the detection of proteins specifically.[3] On account of the presence of these kinds of problems, a variety of improvements are being produced in the fields of preparation of cell lysate and blotting procedures to build up reliable results. Moreover, to achieve more sensitive analysis and overcome the problems associated with western blotting, several different techniques have been developed and utilized, such as far-western blotting, diffusion blotting, single-cell resolution western blotting, and automated microfluidic western blotting.[3]

Presentation

[edit]

Researchers use different software to process and align image-sections for elegant presentation of western blot results. Popular tools include Sciugo, Microsoft PowerPoint, Adobe Illustrator and GIMP.

Enhanced Western Blot

[edit]

Since 1980, western blot has emerged as the most used method in molecular biology for determining the presence and quantity of a certain protein. Over the years, plenty of "advanced" and "optimized" systematical methods have been developed. These developments provide advanced and more sensitive results, with the aid of more advanced imaging technologies and modern fluorescent labeling methods.[2]

Shift-western blot

[edit]

The method with the highest adoption rate for determining DNA-binding proteins and protein-DNA interactions is the electrophoretic mobility shift test. Protein-DNA complexes are analysed via shift-WB. It is created by transferring protein-DNA complexes, in which the DNA in the charged membrane is positioned beneath the nitrocellulose membrane while the proteins are kept in the membrane. Then, specific antibodies are used to identify the proteins, and a radioactive label is used to identify the DNA. Furthermore, the transmitted proteins and DNA can be retrieved and examined in greater detail.[2][44]

Single-cell western blot

[edit]

The single-cell WB (scWB), in addition to the conventional WB, is regarded as a breakthrough in the study of protein subcellular localization and in the evaluation of single-cell protein. When measuring the levels and conditions of protein expression from one cell to the next, it is used. With the aid of single-cell WB, the western blot's selectivity and specificity were expanded to include single-cell protein analysis. The limitations of antibody accuracy and sensitivity are overcome by this technique. Furthermore, because of its versatility, it may be utilized to measure numerous target proteins concurrently from different cell lines and single cells.[2][45]

Quantifiable fluorescence-based western blot

[edit]

The development known as quantifiable fluorescence-based WB (QFWB) enables researchers to carry out comparative expression analysis with better sensitivity and precision than ever before. Quantifiable in QFWB refers to genuinely quantitative with increased sensitivity. This method is employed to identify the minute expression variations between various samples. With the aid of a secondary antibody that has been fluorescently tagged, QFWB produces a linear detection profile. Modern QFWB techniques enable simultaneous dual labeling and are more sensitive to identify minute variations.[2][46]

Quantitative computerized western blot

[edit]

Quantitative computerized western blot analyses the reactivity of individual antibodies to specific antigens to identify immunodominant and immunorecessive determinants using two measures, such as net band intensity and total lane intensity of the WB. The creation of quick serodiagnostic tests and efficient vaccines is made possible by the identification of certain immunodominant antigens. The study looks for serological markers for the early diagnosis of cancer, viral, and autoimmune illnesses using quantitative computerized western blot.[2][47]

High-throughput western blot (DigiWest)

[edit]

It is a technique that combines conventional SDS-PAGE protein resolution with a bead-based microarray platform that immobilizes proteins on microspheres. This combination of protein separation, uniformity, and sensitivity allows for the quick quantification of a number of different protein targets as well as their changes. The benefit of DigiWest is that western blot is carried out using beads-based microarrays, allowing for the simultaneous detection and analysis of hundreds of distinct proteins and their changes using a wide range of varied antibodies.[2][48]

Microfluidic western blot

[edit]

In order to detect many proteins on a single microfluidic chip, microfluidic western blot is carried out using a number of processes, including sample enrichment, protein size, deposition of protein, and then in situ antibody probing. A photoreactive (UV light) polyacrylamide gel and a photopatternable (blue-light) surface are the foundation of this multistep procedure. Due to improvements in analytical performance, WB may now be completed in 10–60 minutes while maintaining high sensitivity detection limits (50 picomoles) and multiplexed component detection levels (femtograms). Therefore, by fusing superb specificity and the high-throughput benefits of multiplexing, WB creates a cornerstone for quick proteomics.[2][49]

Multistrip western blot

[edit]

A enhanced WB technique called multistrip WB is based on the simultaneous transfer of different proteins from a number of polyacrylamide gel strips to a single polyvinylidene difluoride or nitrocellulose membrane. Multistrip WB allows for the simultaneous monitoring of up to nine separate proteins from the same loading of the sample and up to a tenfold increase in data output for a single WB cycle. Systems biology, cell signaling research, and biomedical diagnostics would all benefit from using this technique.[2][50]

Microchip capillary electrophoresis-based western blot

[edit]

The capillary and microchip electrophoresis-based western blot was created to reduce the quantity of protein samples and the amount of time it takes to execute western blot. It contributes to the more sensitive and accurate measurement of various protein targets from any single-cell lysate carried out on a microchip. 400 nanograms of cell lysate are all that is needed to identify and quantify eleven different proteins.[2][51]

See also

[edit]

References

[edit]
  1. ^ a b c d e Mahmood T, Yang PC (September 2012). "Western blot: technique, theory, and trouble shooting". North American Journal of Medical Sciences. 4 (9): 429–434. doi:10.4103/1947-2714.100998 (inactive 2024-07-09). PMC 3456489. PMID 23050259.{{cite journal}}: CS1 maint: DOI inactive as of July 2024 (link)
  2. ^ a b c d e f g h i j k l m n o p q r s t u v w x y z Begum H, Murugesan P, Tangutur AD (June 2022). "Western blotting: a powerful staple in scientific and biomedical research". BioTechniques. 73 (1): 58–69. doi:10.2144/btn-2022-0003. PMID 35775367. S2CID 250175915.
  3. ^ a b c d e f g Mishra M, Tiwari S, Gomes AV (November 2017). "Protein purification and analysis: next generation Western blotting techniques". Expert Review of Proteomics. 14 (11): 1037–1053. doi:10.1080/14789450.2017.1388167. PMC 6810642. PMID 28974114.
  4. ^ Alwine JC, Kemp DJ, Stark GR (December 1977). "Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes". Proceedings of the National Academy of Sciences of the United States of America. 74 (12): 5350–5354. Bibcode:1977PNAS...74.5350A. doi:10.1073/pnas.74.12.5350. PMC 431715. PMID 414220.
  5. ^ Burnette WN (April 1981). ""Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A". Analytical Biochemistry. 112 (2): 195–203. doi:10.1016/0003-2697(81)90281-5. PMID 6266278.
  6. ^ a b Renart J, Reiser J, Stark GR (July 1979). "Transfer of proteins from gels to diazobenzyloxymethyl-paper and detection with antisera: a method for studying antibody specificity and antigen structure". Proceedings of the National Academy of Sciences of the United States of America. 76 (7): 3116–3120. Bibcode:1979PNAS...76.3116R. doi:10.1073/pnas.76.7.3116. PMC 383774. PMID 91164.
  7. ^ a b Towbin H, Staehelin T, Gordon J (September 1979). "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications". Proceedings of the National Academy of Sciences of the United States of America. 76 (9): 4350–4354. Bibcode:1979PNAS...76.4350T. doi:10.1073/pnas.76.9.4350. PMC 411572. PMID 388439.
  8. ^ a b Moritz CP (February 2020). "40 years Western blotting: A scientific birthday toast". Journal of Proteomics. 212: 103575. doi:10.1016/j.jprot.2019.103575. PMID 31706026.
  9. ^ Alexander TS (April 2016). Pasetti MF (ed.). "Human Immunodeficiency Virus Diagnostic Testing: 30 Years of Evolution". Clinical and Vaccine Immunology. 23 (4): 249–253. doi:10.1128/CVI.00053-16. PMC 4820517. PMID 26936099.
  10. ^ Sudha T, Lakshmi V, Teja VD (2006). "Western blot profile in HIV infection". Indian Journal of Dermatology, Venereology and Leprology. 72 (5): 357–360. doi:10.4103/0378-6323.27752. PMID 17050930.
  11. ^ Ingrosso L, Vetrugno V, Cardone F, Pocchiari M (June 2002). "Molecular diagnostics of transmissible spongiform encephalopathies". Trends in Molecular Medicine. 8 (6): 273–280. doi:10.1016/S1471-4914(02)02358-4. PMID 12067613.
  12. ^ Schmitt P, Splettstösser W, Porsch-Ozcürümez M, Finke EJ, Grunow R (August 2005). "A novel screening ELISA and a confirmatory Western blot useful for diagnosis and epidemiological studies of tularemia". Epidemiology and Infection. 133 (4): 759–766. doi:10.1017/s0950268805003742 (inactive 2024-10-30). PMC 2870305. PMID 16050523.{{cite journal}}: CS1 maint: DOI inactive as of October 2024 (link)
  13. ^ Artsob H (March 1993). "Western Blot as a confirmatory test for Lyme disease". The Canadian Journal of Infectious Diseases. 4 (2): 115–116. doi:10.1155/1993/796390. PMC 3250769. PMID 22346434.
  14. ^ De Castro L, Yoshida CF, Gaspar AM, Gomes SA (December 1996). "Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines". Acta Virologica. 40 (5–6): 251–258. PMID 9171452. Retrieved 6 December 2020.
  15. ^ Golden MR, Ashley-Morrow R, Swenson P, Hogrefe WR, Handsfield HH, Wald A (December 2005). "Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic". Sexually Transmitted Diseases. 32 (12): 771–777. doi:10.1097/01.olq.0000175377.88358.f3. PMID 16314775. S2CID 10591513.
  16. ^ "FIV testing – which to use". Catwork. Retrieved 6 December 2020.
  17. ^ Baume N, Jan N, Emery C, Mandanis B, Schweizer C, Giraud S, et al. (May 2015). "Antidoping programme and biological monitoring before and during the 2014 FIFA World Cup Brazil". British Journal of Sports Medicine. 49 (9): 614–622. doi:10.1136/bjsports-2015-094762. PMC 4413745. PMID 25878079.
  18. ^ Reichel C, Benetka W, Lorenc B, Thevis M (November 2016). "Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control". Drug Testing and Analysis. 8 (11–12): 1131–1137. doi:10.1002/dta.2057. PMID 27552163.
  19. ^ Schwenke D (2015). "Application Note: Improved detection of EPO in blood and urine based on novel Velum SAR precast horizontal gels optimized for routine analysis" (PDF).
  20. ^ Sinkala, Elly; Sollier-Christen, Elodie; Renier, Corinne; Rosàs-Canyelles, Elisabet; Che, James; Heirich, Kyra; Duncombe, Todd A.; Vlassakis, Julea; Yamauchi, Kevin A.; Huang, Haiyan; Jeffrey, Stefanie S.; Herr, Amy E. (2017-03-23). "Profiling protein expression in circulating tumour cells using microfluidic western blotting". Nature Communications. 8 (1): 14622. Bibcode:2017NatCo...814622S. doi:10.1038/ncomms14622. ISSN 2041-1723. PMC 5376644. PMID 28332571.
  21. ^ Bouillet, L; Baudet, A E; Deroux, A; Sidibé, A; Dumestre-Perard, C; Mannic, T; Treillard, B; Arboleas, M A; Chiquet, C A; Gulino-Debrac, D G; Vilgrain, I Y (2013-11-01). "Auto-antibodies to vascular endothelial cadherin in humans: association with autoimmune diseases". Laboratory Investigation. 93 (11): 1194–1202. doi:10.1038/labinvest.2013.106. ISSN 0023-6837. PMID 24061286. S2CID 10042681.
  22. ^ Ma, Ping; Dong, Xiaowei; Swadley, Courtney L.; Gupte, Anshul; Leggas, Markos; Ledebur, Harry C.; Mumper, Russell J. (2009-04-01). "Development of Idarubicin and Doxorubicin Solid Lipid Nanoparticles to Overcome Pgp-Mediated Multiple Drug Resistance in Leukemia". Journal of Biomedical Nanotechnology. 5 (2): 151–161. doi:10.1166/jbn.2009.1021. PMC 2805476. PMID 20055093.
  23. ^ Ma, Shao-lin; Hu, Ya-peng; Wang, Fang; Huang, Zhen-cong; Chen, Yi-fan; Wang, Xiao-kun; Fu, Li-wu (2014-09-08). "Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function". Molecular Medicine. 20 (1): 390–399. doi:10.2119/molmed.2014.00059. ISSN 1528-3658. PMC 4212010. PMID 25105301.
  24. ^ Shiga, Yusei; Wakabayashi, Hideki; Miyazawa, Koichi; Kido, Hiroshi; Itoyama, Yasuto (2006-07-01). "14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages". Journal of Clinical Neuroscience. 13 (6): 661–665. doi:10.1016/j.jocn.2005.09.004. ISSN 0967-5868. PMID 16815706. S2CID 42809305.
  25. ^ Balakrishnan, Lavanya; Bhattacharjee, Mitali; Ahmad, Sartaj; Nirujogi, Raja Sekhar; Renuse, Santosh; Subbannayya, Yashwanth; Marimuthu, Arivusudar; Srikanth, Srinivas M; Raju, Rajesh; Dhillon, Mukesh; Kaur, Navjyot; Jois, Ramesh; Vasudev, Vivek; Ramachandra, Yl; Sahasrabuddhe, Nandini A (December 2014). "Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients". Clinical Proteomics. 11 (1): 1. doi:10.1186/1559-0275-11-1. ISSN 1542-6416. PMC 3918105. PMID 24393543.
  26. ^ Wang, Yuji; Li, Dawei; Xu, Nanwei; Tao, Weijian; Zhu, Ruixia; Sun, Rongbin; Fan, Weiwei; Zhang, Ping; Dong, Tianhua; Yu, Long (2011). "Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis". Arthritis Research & Therapy. 13 (6): R193. doi:10.1186/ar3522. ISSN 1478-6354. PMC 3334643. PMID 22117761.
  27. ^ Balakrishnan, Lavanya; Bhattacharjee, Mitali; Ahmad, Sartaj; Nirujogi, Raja Sekhar; Renuse, Santosh; Subbannayya, Yashwanth; Marimuthu, Arivusudar; Srikanth, Srinivas M; Raju, Rajesh; Dhillon, Mukesh; Kaur, Navjyot; Jois, Ramesh; Vasudev, Vivek; Ramachandra, YL; Sahasrabuddhe, Nandini A (2014-01-06). "Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients". Clinical Proteomics. 11 (1): 1. doi:10.1186/1559-0275-11-1. ISSN 1542-6416. PMC 3918105. PMID 24393543.
  28. ^ Wang, Yuji; Li, Dawei; Xu, Nanwei; Tao, Weijian; Zhu, Ruixia; Sun, Rongbin; Fan, Weiwei; Zhang, Ping; Dong, Tianhua; Yu, Long (2011). "Follistatin-like protein 1: a serum biochemical marker reflecting the severity of joint damage in patients with osteoarthritis". Arthritis Research & Therapy. 13 (6): R193. doi:10.1186/ar3522. ISSN 1478-6354. PMC 3334643. PMID 22117761.
  29. ^ Lee YH, Tan HT, Chung MC (November 2010). "Subcellular fractionation methods and strategies for proteomics". Proteomics. 10 (22): 3935–3956. doi:10.1002/pmic.201000289. PMID 21080488. S2CID 29256675.
  30. ^ Barberis E, Marengo E, Manfredi M (2021). "Protein Subcellular Localization Prediction". In Cecconi D (ed.). Proteomics Data Analysis. Methods in Molecular Biology. Vol. 2361. New York, NY: Springer US. pp. 197–212. doi:10.1007/978-1-0716-1641-3_12. ISBN 978-1-0716-1640-6. PMID 34236663. S2CID 235768807.
  31. ^ Maier RH, Maier CJ, Rid R, Hintner H, Bauer JW, Onder K (April 2010). "Epitope mapping of antibodies using a cell array-based polypeptide library". Journal of Biomolecular Screening. 15 (4): 418–426. doi:10.1177/1087057110363821. PMID 20233905. S2CID 210137.
  32. ^ Kong D, Liu J, Jiang Q, Yu Z, Hu X, Guo D, et al. (February 2016). "Production, Characterization, and Epitope Mapping of Monoclonal Antibodies Against Different Subtypes of Rabbit Hemorrhagic Disease Virus (RHDV)". Scientific Reports. 6 (1): 20857. Bibcode:2016NatSR...620857K. doi:10.1038/srep20857. PMC 4754648. PMID 26878800.
  33. ^ Murphy RM, Lamb GD (December 2013). "Important considerations for protein analyses using antibody based techniques: down-sizing Western blotting up-sizes outcomes". The Journal of Physiology. 591 (23): 5823–5831. doi:10.1113/jphysiol.2013.263251. PMC 3872754. PMID 24127618.
  34. ^ Bass JJ, Wilkinson DJ, Rankin D, Phillips BE, Szewczyk NJ, Smith K, Atherton PJ (January 2017). "An overview of technical considerations for Western blotting applications to physiological research". Scandinavian Journal of Medicine & Science in Sports. 27 (1): 4–25. doi:10.1111/sms.12702. PMC 5138151. PMID 27263489.
  35. ^ a b Moritz CP (October 2017). "Tubulin or Not Tubulin: Heading Toward Total Protein Staining as Loading Control in Western Blots" (PDF). Proteomics. 17 (20): 1600189. doi:10.1002/pmic.201600189. PMID 28941183. S2CID 22305461.
  36. ^ Welinder C, Ekblad L (March 2011). "Coomassie staining as loading control in Western blot analysis". Journal of Proteome Research. 10 (3): 1416–1419. doi:10.1021/pr1011476. PMID 21186791.
  37. ^ Ambroz K. (2006-09-20). "Improving quantification accuracy for western blots" (PDF). Image Analysis.
  38. ^ Stennert E, Arold R (October 1973). "[The double external auditory canal (author's transl)]". Hno. 21 (10): 293–296. PMID 4769330.
  39. ^ Gilda JE, Gomes AV (September 2013). "Stain-Free total protein staining is a superior loading control to β-actin for Western blots". Analytical Biochemistry. 440 (2): 186–188. doi:10.1016/j.ab.2013.05.027. PMC 3809032. PMID 23747530.
  40. ^ Moritz CP, Marz SX, Reiss R, Schulenborg T, Friauf E (February 2014). "Epicocconone staining: a powerful loading control for Western blots". Proteomics. 14 (2–3): 162–168. doi:10.1002/pmic.201300089. PMID 24339236. S2CID 206368546.
  41. ^ Mathews ST, Plaisance EP, Kim T (2009). "Imaging Systems for Westerns: Chemiluminescence vs. Infrared Detection". Protein Blotting and Detection. Methods in Molecular Biology. Vol. 536. Humana Press. pp. 499–513. doi:10.1007/978-1-59745-542-8_51. ISBN 978-1-934115-73-2. PMID 19378087.
  42. ^ Kurien BT, Scofield RH (2015). "Other Notable Protein Blotting Methods: A Brief Review". In Kurien BT, Scofield RH (eds.). Western Blotting. Methods in Molecular Biology. Vol. 1312. New York, NY: Springer New York. pp. 487–503. doi:10.1007/978-1-4939-2694-7_51. ISBN 978-1-4939-2693-0. PMC 7301620. PMID 26044032.
  43. ^ Gilda JE, Ghosh R, Cheah JX, West TM, Bodine SC, Gomes AV (2015-08-19). "Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS)". PLOS ONE. 10 (8): e0135392. Bibcode:2015PLoSO..1035392G. doi:10.1371/journal.pone.0135392. PMC 4545415. PMID 26287535.
  44. ^ Harbers M (2015). "Shift-Western Blotting: Separate Analysis of Protein and DNA from Protein–DNA Complexes". In Kurien BT, Scofield RH (eds.). Western Blotting. Methods in Molecular Biology. Vol. 1312. New York, NY: Springer New York. pp. 355–373. doi:10.1007/978-1-4939-2694-7_36. ISBN 978-1-4939-2693-0. PMID 26044017.
  45. ^ Hughes AJ, Spelke DP, Xu Z, Kang CC, Schaffer DV, Herr AE (July 2014). "Single-cell western blotting". Nature Methods. 11 (7): 749–755. doi:10.1038/nmeth.2992. PMC 4077215. PMID 24880876.
  46. ^ Eaton SL, Hurtado ML, Oldknow KJ, Graham LC, Marchant TW, Gillingwater TH, et al. (November 2014). "A guide to modern quantitative fluorescent western blotting with troubleshooting strategies". Journal of Visualized Experiments (93): e52099. doi:10.3791/52099. PMC 4354265. PMID 25490604.
  47. ^ Talmi-Frank D, Jaffe CL, Baneth G (2015). "Quantitative Computerized Western Blotting in Detail". In Kurien BT, Scofield RH (eds.). Western Blotting. Methods in Molecular Biology. Vol. 1312. New York, NY: Springer New York. pp. 141–150. doi:10.1007/978-1-4939-2694-7_18. ISBN 978-1-4939-2693-0. PMID 26043999.
  48. ^ Treindl F, Ruprecht B, Beiter Y, Schultz S, Döttinger A, Staebler A, et al. (September 2016). "A bead-based western for high-throughput cellular signal transduction analyses". Nature Communications. 7 (1): 12852. Bibcode:2016NatCo...712852T. doi:10.1038/ncomms12852. PMC 5036152. PMID 27659302.
  49. ^ Hughes AJ, Herr AE (December 2012). "Microfluidic Western blotting". Proceedings of the National Academy of Sciences of the United States of America. 109 (52): 21450–21455. Bibcode:2012PNAS..10921450H. doi:10.1073/pnas.1207754110. PMC 3535594. PMID 23223527.
  50. ^ Kiyatkin A, Aksamitiene E (2009). "Multistrip Western Blotting to Increase Quantitative Data Output". In Kurien BT, Scofield RH (eds.). Protein Blotting and Detection. Methods in Molecular Biology. Vol. 536. Totowa, NJ: Humana Press. pp. 149–161. doi:10.1007/978-1-59745-542-8_17. ISBN 978-1-934115-73-2. PMC 2923389. PMID 19378054.
  51. ^ Jin S, Furtaw MD, Chen H, Lamb DT, Ferguson SA, Arvin NE, et al. (July 2016). "Multiplexed Western Blotting Using Microchip Electrophoresis". Analytical Chemistry. 88 (13): 6703–6710. doi:10.1021/acs.analchem.6b00705. PMC 5113996. PMID 27270033.
[edit]
Wikimedia Commons has media related to Western blot.
Library resources about
Western immunoblotting
Retrieved from "https://en.wikipedia.org/w/index.php?title=Western_blot&oldid=1254262958"